Project Grant K99CA297022
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$142K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $405,316 Project Grant (CFDA 93.393 Cancer Cause and Prevention Research) to The Ohio State University to investigate the role of inflammatory dietary patterns in colorectal cancer (CRC) development and progression. The research will leverage data from the ColoCare cohort and the Oncology Information Exchange Network to:
Identify gut and tumor microbes associated with the inflammatory Empirical Dietary Inflammatory Pattern (EDIP) score,...
The National Cancer Institute (NCI) awarded a $108,706 Project Grant under the Cancer Research Manpower program (CFDA 93.398) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The grant, effective September 28, 2024 through October 31, 2025, will fund research to investigate the role of diet, particularly fructose and fiber, and the enzyme ACSS2 in regulating metabolism and epigenetics in colorectal cancer. The...
This National Cancer Institute (NCI) Project Grant award (CFDA 93.398 Cancer Research Manpower) provides $150,701 to the University of Illinois to conduct research on the relationship between diet, gut microbiome, and cancer treatment-related cognitive impairment (CRCI) in breast cancer survivors. The key objectives are to:
Determine how adherence to a Mediterranean diet and the gut microbiome are related to cognitive function in breast cancer survivors before, during, and after...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Treatment Research program (CFDA 93.395), aims to develop a novel intervention against colorectal cancer associated with colibactin-producing gut bacteria. The 5-year, $627,422 award to the Regents of the University of Michigan will fund research to engineer commensal E. coli bacteria to display an enzyme that can neutralize the genotoxic effects of colibactin. The research will optimize the surface...
This $536,489 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports research to investigate the interaction between dietary taurine and gut microbiota sulfur metabolism in the development of colorectal cancer (CRC).
The key objectives are to: 1) Determine how dietary taurine and colonization by the sulfur-metabolizing bacterium Bilophila wadsworthia impact intestinal inflammation and tumorigenesis; 2)...
This federal Project Grant award of $2,136,715.00 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) is funding research to harness DNA methylation in peripheral blood for improved colorectal cancer prevention. The primary awardee, Harvard T.H. Chan School of Public Health, is leading a multi-institutional effort that includes sub-awards to Dana-Farber Cancer Institute and Boston University. The key research activities involve using...
This $400,890 Project Grant award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) supports research to profile patient-specific tumor-microbiome interactions and quantitatively analyze the impact on immune checkpoint molecules in colorectal tumors that are unresponsive to immune checkpoint inhibitor immunotherapy. The project will utilize a pathomimetic colorectal cancer organ-on-a-chip model with patient-derived tumor or normal organoids to elucidate the...
The National Cancer Institute (NCI) awarded a $678,399 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to The University of Texas MD Anderson Cancer Center to conduct a prebiotic diet intervention study. The study aims to evaluate the effects of a prebiotic food-enriched diet on the gut microbiome, immune response, and treatment outcomes for metastatic melanoma patients receiving immune checkpoint inhibitor (ICI) therapy. The research will investigate whether manipulating...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $716,672 to Boston University Medical Campus to develop new personalized colorectal cancer (CRC) risk prediction models tailored for Black Americans. The key goals are to:
(A) Develop and validate new CRC risk prediction models for Black men and women using lifestyle, demographic, social, and screening data from large prospective cohorts.
(B) Build dynamic risk models...
This $1,447,286 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports an interdisciplinary study by the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. The study aims to:
Apply an AI-powered automated platform to generate accurate, individualized volumetric measures of adipose tissue compartments and skeletal muscle mass from CT scans of 1,200 colorectal cancer patients enrolled in...